Using mass cytometry to analyze paired blood and CSF samples from MS patients and controls, Johansson et al. identified a small novel B cell population associated with MS, expressing CD49d, CD69, CD27, CXCR3 and human leucocyte antigen DR (HLA-DR) [43]. The gene discussed is CD69; the disease is myeloid sarcoma.